XML 15 R5.htm IDEA: XBRL DOCUMENT v3.26.1
INTERIM CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY - USD ($)
$ in Millions
Total
Issued capital
Net investment attributable to owners of the parent
Capital Surplus
Other capital reserves
Retained earnings
Foreign currency translation
Number of shares outstanding at beginning of period (in shares) (Previously stated) at Dec. 31, 2024   0          
Number of shares outstanding at beginning of period (in shares) (Retroactive effect of Capital Reorganization) at Dec. 31, 2024   206,942,440          
Number of shares outstanding at beginning of period (in shares) at Dec. 31, 2024   206,942,440          
Equity at beginning of period (Previously stated) at Dec. 31, 2024 $ 1,080 $ 0 $ 3,160 $ 0 $ 0 $ 0 $ (2,080)
Equity at beginning of period (Retroactive effect of Capital Reorganization) at Dec. 31, 2024 0 2 (3,160) 2,143 4 1,011 0
Equity at beginning of period at Dec. 31, 2024 1,080 $ 2   2,143 4 1,011 (2,080)
Profit for the period 126         126  
Other comprehensive (loss) income 13       2   11
Total comprehensive income / (loss) 139       2 126 11
Other 2       2    
Number of shares outstanding at end of period (in shares) at Jun. 30, 2025   206,942,440          
Equity at end of period at Jun. 30, 2025 1,221 $ 2 0 2,143 8 1,137 (2,069)
Number of shares outstanding at beginning of period (in shares) (Previously stated) at Mar. 31, 2025   0          
Number of shares outstanding at beginning of period (in shares) (Retroactive effect of Capital Reorganization) at Mar. 31, 2025   206,942,440          
Number of shares outstanding at beginning of period (in shares) at Mar. 31, 2025   206,942,440          
Equity at beginning of period (Previously stated) at Mar. 31, 2025 1,141 $ 0 3,206 0 0 0 (2,065)
Equity at beginning of period (Retroactive effect of Capital Reorganization) at Mar. 31, 2025 0 2 (3,206) 2,143 6 1,055 0
Equity at beginning of period at Mar. 31, 2025 1,141 $ 2   2,143 6 1,055 (2,065)
Profit for the period 82         82  
Other comprehensive (loss) income (4)           (4)
Total comprehensive income / (loss) 78         82 (4)
Other 2       2    
Number of shares outstanding at end of period (in shares) at Jun. 30, 2025   206,942,440          
Equity at end of period at Jun. 30, 2025 1,221 $ 2 0 2,143 8 1,137 (2,069)
Number of shares outstanding at beginning of period (in shares) at Dec. 31, 2025   230,863,624          
Equity at beginning of period at Dec. 31, 2025 1,299 $ 2 0 2,400 24 965 (2,092)
Profit for the period 162         162  
Other comprehensive (loss) income (77)           (77)
Total comprehensive income / (loss) 85         162 (77)
Share-based payments (in shares)   20,000          
Share-based payments 1       1    
Number of shares outstanding at end of period (in shares) at Jun. 30, 2026   230,883,624          
Equity at end of period at Jun. 30, 2026 1,385 $ 2 0 2,400 25 1,127 (2,169)
Number of shares outstanding at beginning of period (in shares) at Mar. 31, 2026   230,863,624          
Equity at beginning of period at Mar. 31, 2026 1,341 $ 2 0 2,400 25 1,050 (2,136)
Profit for the period 77         77  
Other comprehensive (loss) income (33)           (33)
Total comprehensive income / (loss) 44         77 (33)
Share-based payments (in shares)   20,000          
Number of shares outstanding at end of period (in shares) at Jun. 30, 2026   230,883,624          
Equity at end of period at Jun. 30, 2026 $ 1,385 $ 2 $ 0 $ 2,400 $ 25 $ 1,127 $ (2,169)